<![CDATA[Insights]]>https://insights.citeline.comMon, 04 Nov 2024 10:21:26 +0000en1hourly1<![CDATA[Novo Nordisk’s Semaglutide Hits Phase III Marks In NASH]]>https://insights.citeline.com/scrip/r-and-d/clinical-trials/novo-nordisks-semaglutide-hits-phase-iii-marks-in-nash-CBI3UXYJFZDZVI4CDLTMQEU3DE/https://insights.citeline.com/scrip/r-and-d/clinical-trials/novo-nordisks-semaglutide-hits-phase-iii-marks-in-nash-CBI3UXYJFZDZVI4CDLTMQEU3DE/Fri, 01 Nov 2024 22:06:05 +0000